A subgroup analysis from MagnetisMM-3: the efficacy and safety of elranatamab by age and frailty in patients with relapsed or refractory multiple myeloma Meeting Abstract
| Authors: | Raje, N.; Leleu, X.; Lesokhin, A. M.; Mohty , M.; Nooka, A.; Leip, E.; Conte, U.; Vlqueira, A.; Manier, S. |
| Abstract Title: | A subgroup analysis from MagnetisMM-3: the efficacy and safety of elranatamab by age and frailty in patients with relapsed or refractory multiple myeloma |
| Meeting Title: | 2023 Lymphoma, Leukemia and Myeloma Congress |
| Journal Title: | American Journal of Hematology |
| Volume: | 98 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2023 Oct 18-21 |
| Meeting Location: | New York, NY |
| ISSN: | 0361-8609 |
| Publisher: | John Wiley & Sons, Inc. |
| Date Published: | 2023-10-01 |
| Start Page: | S17 |
| End Page: | S18 |
| Language: | English |
| ACCESSION: | WOS:001098086400029 |
| PROVIDER: | wos |
| DOI: | 10.1002/ajh.27112 |
| Notes: | Meeting Abstract: P-028 -- Source: Wos |
